Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 110
- Locations
- 4
- Primary Endpoint
- HPV Vaccine Series Initiation
Study Overview
Brief Summary
The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.
Detailed Description
Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.
Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 11 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine
Exclusion Criteria
- •Parent-child dyads in which the child has received the HPV vaccine
- •Parent-child dyads in which the child is older than 18 at the time of enrollment
- •Non-English speakers
Arms & Interventions
Vaccine Information Statement
Study participants will receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
Video & Vaccine Information Statement
Participants will view an educational video about the HPV vaccine with a male or female narrator. Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
Intervention: Educational Video with Male or Female Narrator (Other)
Outcomes
Primary Outcomes
HPV Vaccine Series Initiation
Time Frame: 0 days
HPV Vaccine Receipt among study participants
HPV Vaccination Series Initiation
Time Frame: 90 days
Number of HPV vaccine doses received among study participants
Secondary Outcomes
- HPV Vaccine Series Initiation (depending on male versus female narrator)(90 days)